- CEO
- Xiang Ying Xu
- Full Time Employees
- 2,889
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Beijing China
- IPO Date
- May 5, 2023
- Business
- Sanbo Hospital Management Group Limited is a China-based healthcare services company primarily engaged in the investment, operation, and management of specialized neurology hospitals and comprehensive medical institutions. Founded in 2003 and headquartered in Beijing, China, the company operates through an integrated clinical medical care, medical education, and scientific research business model, structured around a strong specialty, small comprehensive development framework. The company provides a comprehensive range of clinical and healthcare services, organized into specialized neurosurgical treatments, including brain tumor resection, skull base surgery, cerebrovascular bypass and vascular reconstructive surgery, functional neurosurgery for epilepsy and Parkinson's disease, spinal cord and vertebral surgery, and pediatric neurosurgery; neurological and neuro-oncological care, including neuro-intensive care, neuro-rehabilitation, clinical neurology, medical oncology, and stereotactic radiotherapy such as Gamma Knife surgery; neuro-interventional procedures, including endovascular coiling, embolization, and stenting for cerebrovascular disorders and aneurysms; general clinical medical services across internal medicine, general surgery, orthopedics, cardiology, intensive care, and emergency medicine; diagnostic and laboratory testing services, including neuroimaging, magnetic resonance imaging, computed tomography, digital subtraction angiography, video electroencephalography, and clinical pathology; and hospital management solutions, comprising healthcare investment management, medical technology consulting, hospital operating services, and medical facility management. The company delivers its medical services across major metropolitan and regional markets in China through an expanding hospital network that includes Capital Medical University Sanbo Brain Hospital in Beijing, Chongqing Sanbo Chang'an Hospital, Chongqing Sanbo Jiangling Hospital, Kunming Sanbo Brain Hospital, Luoyang 511 Sanbo Brain Hospital, Xi'an Sanbo Brain Hospital, and Chengdu Dongli Hospital. In recent corporate developments, the company listed its Class A shares on the Shenzhen Stock Exchange ChiNext board under ticker symbol 301293. As part of its strategic nationwide expansion, the company acquired a 70% controlling interest in Sichuan Daxing Guangze Medical Investment Management Co., Ltd. for 420 million yuan, expanding its healthcare network into southwestern China through Chengdu Dongli Hospital. Furthermore, the company completed the relocation and capacity upgrade of its flagship Beijing Sanbo Brain Hospital to its new Dongba campus, expanding total operational capacity to 480 beds and adding specialized radiotherapy and rehabilitation departments; officially opened the newly constructed Xi'an Sanbo Brain Hospital; completed the relocation and opening of the expanded Kunming Sanbo Brain Hospital facility; and advanced development of the Hunan Sanbo Brain Hospital project. The company has also expanded its translational medical research initiatives through academic collaborations with institutions such as Tsinghua University and participation in clinical research trials evaluating interventional brain-computer interface technologies for neurological and motor rehabilitation.